SCIENTIFIC ADVISORY BOARD
From obstetrics and gynaecology to neurology and pharmacology—our Scientific Advisory Board (SAB) is made up of recognized authorities from all the fields that intersect in menstrual-related disorders.
Every member of our SAB has advanced their field significantly over the course of decades of often award-winning work. Together, they provide Asarina Pharma with world-class support and guidance on every aspect of its research, technology and treatments.
Torbjörn Bäckström Chairman
MD, PhD, co-founder and CEO of Umecrine AB, is professor at the Department of Clinical Science, Obstetrics and Gynecology, Umeå University. He is also head of the Umeå Neurosteroid Research Center. Professor Bäckström’s main focus of research since 1972 is the effect of sex and stress hormones on the brain and conditions induced by these hormones, he has more than 400 scientific publications within this area.
Marie Bixo Scientific board member
Marie Bixo is a Professor and Consultant Physician at the Department of Clinical Science, Obstetrics and Gynaecology Unit, Umeå University, Sweden. Awards for her work in the field include the 2009 OGU Prize from the Swedish Association for Obstetrics and Gynaecology. Prof Bixo received her M.D. degree in 1984 and her Doctorate in Medicine in 1987, both from Umeå University. She became a specialist in obstetrics and gynaecology in 1993, after training at Mölndal Hospital. 1995. In 2011 she was employed at Umeå University, first as Senior Lecturer and Associate Professor and then as Professor. In 2012 she became a professor at Karolinska Institute, returning to Umeå University as Professor of Obstetrics and Gyneacology in 2014. She is interviewed regularly as a trusted authority on menstrual issues in Swedish and Scandinavian media.
C. Neill Epperson, M.D. Scientific board member
Dr. Neill Epperson is Professor of Psychiatry and Obstetrics and Gynecology at the Perelman School of Medicine where she is also the Founder and Director of the Penn Center for Women’s Behavioral Wellness. The Center’s mission is to improve women’s health through greater understanding of the impact of hormones and gender on common medical conditions. Dr Epperson also directs the cross-university center, Penn PROMOTES Research on Sex and Gender in Health and Penn’s Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12 program. Dr. Epperson received her M.D. degree at the University of North Carolina at Chapel Hill and completed her postdoctoral and research training in psychiatry at Yale University School of Medicine where she was Associate Professor of Psychiatry before joining Penn in the fall of 2009.
Anne MacGregor Scientific board member
Dr Anne MacGregor is a recognized authority on menstrual migraine and headache with over 200 research papers and five books to her name. Dr MacGergor’s MBBS medical degree was from St Bartholomew’s Hospital, London, where she began training in headache medicine and studying vital links between the menstrual cycle and migraine. Her Doctorate in Medicine was from the University of London, and her MSc MedEd (Masters in Medical Education) from the Royal College of Physicians and University College London. Dr MacGregor is Honorary Professor at the Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, Barts, and the London School of Medicine and Dentistry. In 2002 she received the Elizabeth Garret Anderson Award, awarded to women who have made an extraordinary contribution to long-term work in headache relief. In 2011 she received the Special Recognition Award and Honorary Life Membership from the International Headache Society.
Marco Bortolato Scientific board member
Marco Bortolato is currently Associate Professor of Pharmacology and Toxicology at the Department of Pharmacology and Toxicology at the University of Utah. He is a recognised authority on neurodevelopmental disorders. He received his M.D. degree in 2000 from the University of Cagliari, Italy, and gained his Doctorate in Pharmacology there in 2004. Marco Bortolato’s key area of scientific interest is the interaction between lipid mediators (including neuroactive steroids and endocannabinoids) and key brain neurotransmitters. The long-term goal of this research is the development of novel therapeutic agents for the treatment of pathological aggression, autism-spectrum disorder, Tourette syndrome, schizophrenia and impulse-control disorders (such as pathological gambling).
Günther Deuschl Scientific board member
Prof. Dr. Dr. h.c. Günther Deuschl received his MD at the University of Munich. From 1981 to 1982 he trained at the Department of Neurology of the Universities in Munich and subsequently in Freiburg where he was promoted to assistant professor in 1988. In 1991 he spent a sabbatical at the National Institutes of Health, Bethesda/USA. In 1995 he was elected as full Professor of Neurology at the Christian-Albrechts-University in Kiel and chairman of the Department of Neurology. He retired in 2016 and is working currently as a senior researcher at the Department. His research interests are focused on the clinical features and treatment of Movement Disorders, Parkinson’s disease, essential and other tremors and deep Brain Stimulation. A special interest covers clinical studies on deep brain stimulation for Parkinson’s disease and the pathophysiology of movement disorders.
He has published more than 580 Pubmed listed papers with > 42.000 citations. He has led the guideline committees of the German Neurological Society ‘Parkinson’s disease’ as well as ‘Dementia’ and many scientific committees. He holds honorary professorships in Hangzhou and Shanghai and is doctor honoris causa of the Moldovian Academy of Sciences. He is honorary member of the International Movement Disorder, the Austrian Parkinson Society as well as the French, Moldavian and Rumanian Neurological Societies. He has served in many functions for different scientific societies. He is past president of the German Society of Neurology and of the International Movement Disorder Society. Currently he is president of the European Academy of Neurology.